Codexis Announces New Employment Inducement Grants
March 09, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to two new employees as...
Codexis to Participate in Cowen 43rd Annual Health Care Conference
February 27, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced that management will participate in both a panel discussion...
Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results
February 23, 2023 16:06 ET
|
Codexis, Inc.
Biotherapeutics Application of CodeEvolver® Validated by Recent Data Supporting the Potential for Three Upcoming Investigational New Drug Applications Cash Runway Through End of 2024 Funds Important...
Codexis and Nestlé Health Science Announce Interim Results from Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency
February 23, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, and Nestlé Health Science, a leader in the science of nutrition, today...
Codexis Announces Several Key Presentations from its Gene Therapy Programs at 19th Annual WORLDSymposium™
February 22, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today highlights several key presentations from its gene therapy programs...
Codexis Announces New Employment Inducement Grants
February 15, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the grant of an inducement award to the Company’s recently...
Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23
February 09, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the fourth...
Codexis Announces Appointment of Sri Ryali as Chief Financial Officer
January 23, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Sri Ryali as Chief Financial Officer...
Codexis Announces Appointment of H. Stewart Parker to Board of Directors
December 20, 2022 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of H. Stewart Parker to its Board of...
Codexis Provides Update on Prioritized Corporate Strategy
November 29, 2022 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced an update on the Company’s ongoing plan to prioritize its...